Stock Analysis, Dividends, Split History

XXII / 22nd Century Group, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)378.10
Enterprise Value ($M)361.05
Book Value ($M)72.51
Book Value / Share0.58
Price / Book5.03
NCAV ($M)52.94
NCAV / Share0.43
Price / NCAV6.88
Share Statistics
Common Shares Outstanding 124,136,087
Common Stock Shares Outstanding 123,569,367
Scoring Models
Piotroski F-Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.17
Return on Assets (ROA)-0.47
Return on Equity (ROE)-0.54
Balance Sheet (mrq) ($M)
Quick Ratio9.70
Current Ratio10.21
Income Statement (mra) ($M)
Sales Revenue Goods Net16,600,244.00
Operating Income-13.30
Net Income-13.03
Earnings Per Share Basic And Diluted-0.13
Earnings Per Share Diluted-0.13
Earnings Per Share Basic-0.13
Cash Flow Statement (mra) ($M)
Cash From Operations-12.07
Cash from Investing-60.59
Cash from Financing-60.59
Identifiers and Descriptors
Central Index Key (CIK)1347858
Related CUSIPS
90137F903 90137F953
Industry Groups
SIC 2111 - Cigarettes

Split History

Stock splits are used by 22nd Century Group, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon
XXII : 22nd Century Group Stock Analysis and Research Report

2017-10-09 - Asif

22nd Century Group is a plant biotechnology company focused on (i) potentially reduced risk tobacco cigarettes and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding, and (ii) research and development of unique cannabis/hemp plants through genetic engineering and plant breeding to alter levels of cannabinoids for new medicines and improved agricultural uses. The company has an extensive intellectual property portfolio of issued patents and patent applications relating to the tobacco and cannabis plants. Its management team is focused on monetizing its intellectual property portfolio, obtaining regulatory approval to market both its reduced exposure cigarettes and its smoking cessation product in development, and developing and commercializing high value products derived from its unique cannabis/hemp plants. Additional information about its business and operations is contained in tis Annual Report on ...

Related News Stories

22nd Century Will Reap Massive Benefits From FDA Decree

2018-10-04 seekingalpha
FDA mandate dictates that all cigarettes be Very Low Nicotine. 22nd Century is the only company with patents to accomplish this. (35-4)

22nd Century Group: An Interesting, Moving Target

2018-09-18 seekingalpha
If XXII's hemp business keeps going in this direction, XXII could turn out to be a good long. (36-5)

Is Vector Group Dividend For Real?

2018-06-18 seekingalpha
The company’s business model consists of investing the proceeds from their discount cigarette business into a high-end real estate business. (389-3)

SHU Portfolio: An Update On 22nd Century Group

2018-05-07 seekingalpha
It's an attractive risk/reward play but the underlying story warrants patience but we still think that will pay off. (381-9)

22nd Century Group's (XXII) CEO Henry Sicignano on Q1 2018 Results - Earnings Call Transcript

2018-05-05 seekingalpha
22nd Century Group, Inc. (NYSEMKT:XXII) Q1 2018 Results Conference Call May 3, 2018 4:00 PM ET (383-6)

CUSIP: 90137F103